BACKGROUND: Acute respiratory distress syndrome (ARDS) is common after traumatic brain injury (TBI) and is associated with worse neurologic outcomes and longer hospitalization. However, the incidence and associated causes of ARDS in isolated TBI have not been well studied. METHODS: We performed a subgroup analysis of 210 consecutive patients with isolated severe TBI enrolled in a prospective observational cohort at a Level 1 trauma center between 2005 and 2014. Subjects required endotracheal intubation and had isolated severe TBI defined by a head Abbreviated Injury Scale (AIS) score of 3 or greater and AIS score lower than 3 in all other categories. ARDS within the first 8 days of admission was rigorously adjudicated using Berlin criteria. Regression analyses were used to test the association between predictors of interest and ARDS. RESULTS: The incidence of ARDS in the first 8 days after severe isolated TBI was 30%. Patients who developed ARDS were administered more crystalloids (4.3 L vs. 3.5 L, p = 0.005) and blood products in the first 12 hours of admission. Patients with ARDS had significantly worse clinical outcomes measured at 28 days, including longer median intensive care unit and hospital stays (4 days vs. 13 days, p < 0.001, and 7.5 days vs. 14.5 days, p < 0.001, respectively). In unadjusted logistic regression analyses, the odds of developing ARDS were significantly associated with head AIS score (odds ratio [OR], 1.8; p = 0.018), male sex (OR, 2.9; p = 0.012), and early transfusion of platelets (OR, 2.8; p = 0.003). These associations were similar in a multivariate logistic regression model. CONCLUSION: In the era of balanced hemostatic resuscitation practices, severity of head injury, male sex, early crystalloids, and early transfusion of platelets are associated with a higher risk of ARDS after severe isolated TBI. Early transfusion of platelets after severe TBI may be a modifiable risk factor for ARDS, and these findings invite further investigation into causal mechanisms driving this observed association. LEVEL OF EVIDENCE: Prognostic/epidemiologic study, level III.
BACKGROUND:Acute respiratory distress syndrome (ARDS) is common after traumatic brain injury (TBI) and is associated with worse neurologic outcomes and longer hospitalization. However, the incidence and associated causes of ARDS in isolated TBI have not been well studied. METHODS: We performed a subgroup analysis of 210 consecutive patients with isolated severe TBI enrolled in a prospective observational cohort at a Level 1 trauma center between 2005 and 2014. Subjects required endotracheal intubation and had isolated severe TBI defined by a head Abbreviated Injury Scale (AIS) score of 3 or greater and AIS score lower than 3 in all other categories. ARDS within the first 8 days of admission was rigorously adjudicated using Berlin criteria. Regression analyses were used to test the association between predictors of interest and ARDS. RESULTS: The incidence of ARDS in the first 8 days after severe isolated TBI was 30%. Patients who developed ARDS were administered more crystalloids (4.3 L vs. 3.5 L, p = 0.005) and blood products in the first 12 hours of admission. Patients with ARDS had significantly worse clinical outcomes measured at 28 days, including longer median intensive care unit and hospital stays (4 days vs. 13 days, p < 0.001, and 7.5 days vs. 14.5 days, p < 0.001, respectively). In unadjusted logistic regression analyses, the odds of developing ARDS were significantly associated with head AIS score (odds ratio [OR], 1.8; p = 0.018), male sex (OR, 2.9; p = 0.012), and early transfusion of platelets (OR, 2.8; p = 0.003). These associations were similar in a multivariate logistic regression model. CONCLUSION: In the era of balanced hemostatic resuscitation practices, severity of head injury, male sex, early crystalloids, and early transfusion of platelets are associated with a higher risk of ARDS after severe isolated TBI. Early transfusion of platelets after severe TBI may be a modifiable risk factor for ARDS, and these findings invite further investigation into causal mechanisms driving this observed association. LEVEL OF EVIDENCE: Prognostic/epidemiologic study, level III.
Authors: Herbert P Wiedemann; Arthur P Wheeler; Gordon R Bernard; B Taylor Thompson; Douglas Hayden; Ben deBoisblanc; Alfred F Connors; R Duncan Hite; Andrea L Harabin Journal: N Engl J Med Date: 2006-05-21 Impact factor: 91.245
Authors: Alexander P J Vlaar; Jorrit J Hofstra; Wim Kulik; Henk van Lenthe; Rienk Nieuwland; Marcus J Schultz; Marcel M Levi; Joris J T H Roelofs; Anton T J Tool; Dirk de Korte; Nicole P Juffermans Journal: Blood Date: 2010-05-17 Impact factor: 22.113
Authors: Benjamin M Howard; Lucy Z Kornblith; Carolyn M Hendrickson; Brittney J Redick; Amanda S Conroy; Mary F Nelson; Rachael A Callcut; Carolyn S Calfee; Mitchell Jay Cohen Journal: J Trauma Acute Care Surg Date: 2015-04 Impact factor: 3.313
Authors: Dennis Yong Kim; Michael O'Leary; Andrew Nguyen; Amy Kaji; Scott Bricker; Angela Neville; Fred Bongard; Brant Putnam; David Plurad Journal: J Neurotrauma Date: 2015-09-08 Impact factor: 5.269
Authors: Catherine O Anglin; Jeffrey S Spence; Matthew A Warner; Christopher Paliotta; Caryn Harper; Carol Moore; Ravi Sarode; Christopher Madden; Ramon Diaz-Arrastia Journal: J Neurosurg Date: 2012-12-21 Impact factor: 5.115
Authors: Bruce D Spiess; David Royston; Jerrold H Levy; Jane Fitch; Wulf Dietrich; Simon Body; John Murkin; Andrea Nadel Journal: Transfusion Date: 2004-08 Impact factor: 3.157
Authors: Francis J Castellino; Michael P Chapman; Deborah L Donahue; Scott Thomas; Ernest E Moore; Max V Wohlauer; Braxton Fritz; Robert Yount; Victoria Ploplis; Patrick Davis; Edward Evans; Mark Walsh Journal: J Trauma Acute Care Surg Date: 2014-05 Impact factor: 3.313
Authors: David Plurad; Mathew Martin; Donald Green; Ali Salim; Kenji Inaba; Howard Belzberg; Demetrios Demetriades; Peter Rhee Journal: J Trauma Date: 2007-07
Authors: Marcel Winkelmann; Jan-Dierk Clausen; Pascal Graeff; Christian Schröter; Christian Zeckey; Sanjay Weber-Spickschen; Philipp Mommsen Journal: In Vivo Date: 2019 Sep-Oct Impact factor: 2.155
Authors: Lucy Z Kornblith; Anamaria J Robles; Amanda S Conroy; Carolyn M Hendrickson; Carolyn S Calfee; Alexander T Fields; Rachael A Callcut; Mitchell J Cohen Journal: J Trauma Acute Care Surg Date: 2018-11 Impact factor: 3.313
Authors: Elizabeth A Middleton; Matthew T Rondina; Hansjorg Schwertz; Guy A Zimmerman Journal: Am J Respir Cell Mol Biol Date: 2018-07 Impact factor: 6.914
Authors: Lucy Z Kornblith; Anna Decker; Amanda S Conroy; Carolyn M Hendrickson; Alexander T Fields; Anamaria J Robles; Rachael A Callcut; Mitchell J Cohen Journal: J Trauma Acute Care Surg Date: 2019-11 Impact factor: 3.313
Authors: Nadine A Kerr; Juan Pablo de Rivero Vaccari; Sam Abbassi; Harmanpreet Kaur; Ronald Zambrano; Shu Wu; W Dalton Dietrich; Robert W Keane Journal: J Neurotrauma Date: 2018-06-08 Impact factor: 5.269
Authors: Carolyn M Hendrickson; Stuart L Gibb; Byron Y Miyazawa; Sheila M Keating; Erin Ross; Amanda S Conroy; Carolyn S Calfee; Shibani Pati; Mitchell J Cohen Journal: Trauma Surg Acute Care Open Date: 2018-06-27
Authors: Nadine A Kerr; Juan Pablo de Rivero Vaccari; Oliver Umland; M Ross Bullock; Gregory E Conner; W Dalton Dietrich; Robert W Keane Journal: Cells Date: 2019-01-18 Impact factor: 6.600